相关实验视频
Updated: Jul 11, 2025
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
在精神病性抑郁症的维持阶段的抗精神病药物
Ahmed Al-Wandi1, Mikael Landén2,3, Axel Nordenskjöld1
1University Health Care Research Centre, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Acta psychiatrica Scandinavica
|November 6, 2023
概括
与联合治疗相比,抗抑郁药单一治疗与精神病单极性抑郁症患者的再入院和自杀风险降低有关. 添加抗精神病药物对这些结果没有显著的益处.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 精神病单极性抑郁症带来了复发和自杀的重大风险.
- 精神病单极性抑郁症的维持治疗策略对于患者的治疗结果至关重要.
- 抗精神病药物作为抗抑郁药的辅助维持疗法的作用需要进一步研究.
研究的目的:
- 为了比较精神病单极性抑郁症患者仅用抗抑郁药治疗的抗抑郁药与抗抑郁药加抗精神病药物的再入院和自杀的风险.
- 评估组合疗法与单一疗法的疗效,以预防这种患者群体的精神病再入院和自杀.
主要方法:
- 从瑞典国家登记册 (2007-2016) 中确定了一组由4391名被诊断患有精神病单极性抑郁症的住院患者组成的队列.
- 根据药房记录,患者被分类为抗抑郁药单一治疗或抗抑郁药加抗精神病药物联合治疗组,在出院后14天内.
- 用2年的随访期来评估任何精神疾病,自杀企图或完成自杀的医院再入院的主要结果,分析使用多个共同变量调整的考克斯回归.
主要成果:
- 该研究确定了组合治疗组中的2972名患者和单一治疗组中的1419名患者.
- 2年后,42.3%的组合组和36.6%的单一治疗组经历了主要结果.
- 抗抑郁药单一治疗与重新入院或自杀的风险降低显著相关 (危险比率=0.86;95% CI:0.77-0.95).
结论:
- 将抗精神病药物添加到精神病单极性抑郁症的抗抑郁药物维持治疗中,并没有显示出降低再入院或自杀风险的优势.
- 这些发现表明,目前的证据不支持在这个患者群体中常规使用抗精神病药物进行维持治疗.
- 迫切需要进一步的研究,以澄清抗精神病药物在精神病单极性抑郁症的维持阶段的作用和疗效,并考虑潜在的副作用.
相关概念视频
01:28Psychosis and Antipsychotic Drugs: Overview
289
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
289
01:26Psychosis: Goals of Pharmacotherapy
143
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
143
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
229
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
229
01:24Mania and Antimanic Drugs: Overview
202
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
202
01:28Drug Therapy
47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
47
01:23Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252